NovAccess Global to Participate in National Brain Tumor Society's Annual Glioblastoma Awareness Day

CLEVELAND, OH / ACCESSWIRE / July 13, 2023 / NovAccess Global Inc. (OTCQB:XSNX), a biomedical company developing novel immunotherapies for brain tumor patients, today announced that its Chief Executive Officer Dr. Dwain K. Irvin will be participating in the National Brain Tumor Society's (NBTS) fifth annual Glioblastoma Awareness Day on July 19, 2023 in support of the fight against one of the fastest growing and aggressive brain tumors.

"NovAccess Global has been steadily enhancing its position at the forefront of immunotherapies and has advanced its leadership in development of the most efficacious treatment strategies for glioblastoma (GBM). With this standing in the healthcare community, it is important that we participate in all major industry events such as the fifth annual Glioblastoma Awareness Day," said Dr. Irvin. "We commend the NBTS for its efforts and are pleased to be doing our part as we move into and through clinical trials toward the development of a novel immunotherapeutic approach to treating brain tumor patients with GBM."

NBTS Data on Glioblastoma

14,490 Americans who will receive a glioblastoma diagnosis in 2023

6.9% is the five-year survival rate for glioblastoma patients

10,000 Americans will succumb to glioblastoma this year

NovAccess Global will join event organizers in their mission to shine a light on glioblastoma, the most common, complex, treatment-resistant, and deadliest type of brain cancer. According to the event website, NBTS spearheaded this annual day of awareness in 2019 to support survivors and their loved ones, to remember those who are no longer with us, and to honor leaders working toward a cure and better quality of life for those living with this devastating disease. Leading up to the 2023 event, NBTS will be sharing stories, information, and ways to take action and raise awareness about glioblastoma. On GBM Day, NBTS will share a video program highlighting patient and caregiver experiences. Similarly supportive stories are available on NovAccess Global's social media assets and website via the links toward the end of this press release.

According to the National Brain Tumor Society website, your support is critical to power the most promising science, make broad changes at the government level, and help patients and caregivers today. Help shed light on this devastating disease. To make a donation or provide support, please use the following link: